Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS EXPLAINER

US lawsuit threatens access to abortion drug: the science behind the case

Judge’s decision could ban mifepristone across the country, and weaken the Food and Drug Administration’s authority.
  1. Mariana Lenharo
    View author publications

    You can also search for this author in PubMed  Google Scholar

A lawsuit in Texas not only has the potential to further restrict abortion access in the United States — but it could also set a dangerous precedent by overturning the approval of a medication by the US Food and Drug Administration (FDA).

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 615, 16-17 (2023)

doi: https://doi.org/10.1038/d41586-023-00529-9

References

  1. Raymond, E. G. et al. Contraception 87, 26–37 (2013).

    Article  PubMed  Google Scholar 

  2. Moseson, H. et al. Lancet Glob. Health 10, E105–E113 (2022).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links